BullFrog AI Holdings has entered a commercial agreement with a [...]

Tozorakimab has met its primary endpoint in two replicate Phase [...]

Researchers identify an IL-1β-driven inflammatory loop behind bone damage and [...]

FoRx Therapeutics presents preclinical data on FORX-428, a PARG inhibitor [...]

Complement Therapeutics doses first patient in Phase 1/Phase 2 Opti-GAIN [...]

Quotient Therapeutics and Merck sign a multi-year collaboration to identify [...]

Primerdesign and Origin Sciences partner to develop a DNA extraction [...]

insitro and Bristol Myers Squibb have expanded their ALS collaboration [...]

Laigo Bio has completed a €17 million seed financing round [...]

Liver-metabolic disease is linked to increased heart failure risk in [...]